New product intros (albuvirtide, anakinra [new indication], cemiplimab-rwlc, damoctocog alfa pegol, doravirine, doravirine/lamivudine/tenofovir disoproxil fumarate [new combination], duvelisib, pyrotinib maleate, tafenoquine succinate, testosterone gel [new formulation])
Keyword(s):
Keyword(s):
Keyword(s):